Cargando…

Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma

The aim of presented research is to develop a simple and quick method of spectrophotometric detection for the determination of doxorubicin hydrochloride in blood and plasma. Anthracycline antibiotics are among the most effective antineoplastic agents. However, despite their high efficacy in the trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sikora, Tomasz, Morawska, Karolina, Lisowski, Wiesław, Rytel, Paweł, Dylong, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880482/
https://www.ncbi.nlm.nih.gov/pubmed/35215225
http://dx.doi.org/10.3390/ph15020112
_version_ 1784659213742505984
author Sikora, Tomasz
Morawska, Karolina
Lisowski, Wiesław
Rytel, Paweł
Dylong, Agnieszka
author_facet Sikora, Tomasz
Morawska, Karolina
Lisowski, Wiesław
Rytel, Paweł
Dylong, Agnieszka
author_sort Sikora, Tomasz
collection PubMed
description The aim of presented research is to develop a simple and quick method of spectrophotometric detection for the determination of doxorubicin hydrochloride in blood and plasma. Anthracycline antibiotics are among the most effective antineoplastic agents. However, despite their high efficacy in the treatment of various types of cancer, their administration is limited primarily because they exhibit myocardial toxicity. This may be a limiting factor in the dosage of medications; nevertheless, drugs exhibiting this mechanism of action constitute a very important group of chemotherapeutics. One of the more widely studied antibiotics from the anthracycline group is doxorubicin. It exhibits the highest antineoplastic activity from among a number of derivative compounds. Because of the adverse effects of doxorubicin, especially cardiotoxicity, it is important to maintain control of its concentration in body fluids. The method in the study consists of extraction doxorubicin from the plasma or blood and measurements of the absorbance of light in the visible light range in a DOX solution with respect to a reference sample. The research used blood and plasma samples spiked with doxorubicin to give concentrations in the range of 0.2–10 µg/mL. Obtained LODs were 1.6 µg/mL and 1.2 µg/mL, respectively.
format Online
Article
Text
id pubmed-8880482
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88804822022-02-26 Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma Sikora, Tomasz Morawska, Karolina Lisowski, Wiesław Rytel, Paweł Dylong, Agnieszka Pharmaceuticals (Basel) Article The aim of presented research is to develop a simple and quick method of spectrophotometric detection for the determination of doxorubicin hydrochloride in blood and plasma. Anthracycline antibiotics are among the most effective antineoplastic agents. However, despite their high efficacy in the treatment of various types of cancer, their administration is limited primarily because they exhibit myocardial toxicity. This may be a limiting factor in the dosage of medications; nevertheless, drugs exhibiting this mechanism of action constitute a very important group of chemotherapeutics. One of the more widely studied antibiotics from the anthracycline group is doxorubicin. It exhibits the highest antineoplastic activity from among a number of derivative compounds. Because of the adverse effects of doxorubicin, especially cardiotoxicity, it is important to maintain control of its concentration in body fluids. The method in the study consists of extraction doxorubicin from the plasma or blood and measurements of the absorbance of light in the visible light range in a DOX solution with respect to a reference sample. The research used blood and plasma samples spiked with doxorubicin to give concentrations in the range of 0.2–10 µg/mL. Obtained LODs were 1.6 µg/mL and 1.2 µg/mL, respectively. MDPI 2022-01-18 /pmc/articles/PMC8880482/ /pubmed/35215225 http://dx.doi.org/10.3390/ph15020112 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sikora, Tomasz
Morawska, Karolina
Lisowski, Wiesław
Rytel, Paweł
Dylong, Agnieszka
Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma
title Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma
title_full Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma
title_fullStr Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma
title_full_unstemmed Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma
title_short Application of Optical Methods for Determination of Concentration of Doxorubicin in Blood and Plasma
title_sort application of optical methods for determination of concentration of doxorubicin in blood and plasma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880482/
https://www.ncbi.nlm.nih.gov/pubmed/35215225
http://dx.doi.org/10.3390/ph15020112
work_keys_str_mv AT sikoratomasz applicationofopticalmethodsfordeterminationofconcentrationofdoxorubicininbloodandplasma
AT morawskakarolina applicationofopticalmethodsfordeterminationofconcentrationofdoxorubicininbloodandplasma
AT lisowskiwiesław applicationofopticalmethodsfordeterminationofconcentrationofdoxorubicininbloodandplasma
AT rytelpaweł applicationofopticalmethodsfordeterminationofconcentrationofdoxorubicininbloodandplasma
AT dylongagnieszka applicationofopticalmethodsfordeterminationofconcentrationofdoxorubicininbloodandplasma